Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Metastatic breast cancer: HER2+

From clinical trials to real life data: Current treatment standards and outcomes among HER2+ metastatic breast cancer patients


23 May 2020


Metastatic breast cancer: HER2+


Suzette Delaloge


S. Delaloge

Author affiliations

  • Breast Oncology Department, Institut Gustave Roussy, 94805 - Villejuif/FR


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings